ts-121 ts-121 ts-121 (thy1773) is an orally active, selective vasopressin v1b receptor antagonist which is under development by taisho pharmaceutical for the adjunctive treatment of major depressive disorder. as of may 2017, it is in phase ii clinical trials for this indication. ts-121clinical dataother namests-1211routes ofadministrationby mouth